First-line treatment of advanced non-small-cell lung cancer (NSCLC) with vinorelbine and cisplatin.

被引：0
|
作者：
Bobilev, D [1 ]
Ariad, S [1 ]
Geffen, DB [1 ]
Cohen, Y [1 ]
机构：
[1] Soroka Univ, Med Ctr, Beer Sheva, Israel
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
539P
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [41] BIWEEKLY CISPLATIN AND GEMCITABINE AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER
    Benekli, Mustafa
    Gunaydin, Yusuf
    Inanc, Mevlude
    Ozkan, Metin
    Demirci, Ayse
    Demirci, Umut
    Suner, Ali
    Karaca, Halit
    Tonyali, Onder
    Berk, Veli
    Buyukberber, Suleyman
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S563 - S563
  • [42] Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
    Rosell, R.
    Robinet, G.
    Szczesna, A.
    Ramlau, R.
    Constenla, M.
    Mennecier, B. C.
    Pfeifer, W.
    O'Byrne, K. J.
    Welte, T.
    Kolb, R.
    Pirker, R.
    Chemaissani, A.
    Perol, M.
    Ranson, M. R.
    Ellis, P. A.
    Pilz, K.
    Reck, M.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 362 - 369
  • [43] Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer
    Baldini, E
    Tibaldi, C
    Chella, A
    Angeletti, CA
    Silvano, G
    Andrei, A
    Algeri, R
    Conte, PF
    ANNALS OF ONCOLOGY, 1996, 7 (07) : 747 - 749
  • [44] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    de Carpeño, JC
    Barón, MG
    Aguiar, J
    Chacón, JI
    Feliu, J
    García, MJ
    Madroñal, C
    Colmenarejo, A
    Sánchez, JJ
    Ordóñez, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 266 - 271
  • [45] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    Javier Castro de Carpeño
    M. González Barón
    J. Aguiar
    J. I. Chacón
    J. Feliu
    M. J. García
    C. Madroñal
    A. Colmenarejo
    J. J. Sánchez
    A. Ordóñez
    Cancer Chemotherapy and Pharmacology, 2006, 58
  • [46] First-Line Single Agent Treatment With Gefitinib in Advanced Non-Small-Cell Lung Cancer Patients
    Yin, Yong-mei
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 325 - 325
  • [47] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Heather A. Wakelee
    Gary Middleton
    David Dunlop
    Rodryg Ramlau
    Natasha Leighl
    Desiree Hao
    Arturo Lopez-Anaya
    Petr Zatloukal
    Charlotte D. Jacobs
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 815 - 824
  • [48] First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype
    Tiseo, Marcello
    Bartolotti, Marco
    Gelsomino, Francesco
    Ardizzoni, Andrea
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 425 - 435
  • [49] First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer
    Yin Y.-M.
    Geng Y.-T.
    Shao Y.-F.
    Hu X.-L.
    Li W.
    Shu Y.-Q.
    Wang Z.-X.
    Journal of Experimental & Clinical Cancer Research, 29 (1)
  • [50] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Wakelee, Heather A.
    Middleton, Gary
    Dunlop, David
    Ramlau, Rodryg
    Leighl, Natasha
    Hao, Desiree
    Lopez-Anaya, Arturo
    Zatloukal, Petr
    Jacobs, Charlotte D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 815 - 824
12345